Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$4.56B |
| 2 |
Broadcom
AVGO
|
+$441M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$281M |
| 4 |
NVIDIA
NVDA
|
+$278M |
| 5 |
Microsoft
MSFT
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$2.05B |
| 2 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$1.6B |
| 3 |
Lennox International
LII
|
+$284M |
| 4 |
Itaú Unibanco
ITUB
|
+$247M |
| 5 |
Intuit
INTU
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Financials | 19.13% |
| 3 | Healthcare | 9.52% |
| 4 | Industrials | 9.41% |
| 5 | Communication Services | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
ResMed
RMD
$30.7B
| $16.1M | 0.01% |
66,972
+6,188
| +10% | +$1.58M |
|
352
Neurocrine Biosciences
NBIX
$16.6B
| $15.9M | 0.01% |
112,242
+17,447
| +18% | +$2.53M |
|
353
iShares MSCI Australia ETF
EWA
$1.45B
| $15.9M | 0.01% |
606,997
+36,393
| +6% | +$963K |
|
354
Tesla
TSLA
$1.3T
| $15.8M | 0.01% |
35,196
+4,574
| +15% | +$2.03M |
|
355
Qualys
QLYS
$6.35B
| $15.8M | 0.01% |
118,743
-12,909
| -10% | -$1.78M |
|
|
SNV
356
DELISTED
Synovus
SNV
| $15.7M | 0.01% |
313,348
+68,324
| +28% | +$3.28M |
|
|
357
Lennox International
LII
$15.2B
| $15.4M | 0.01% |
31,684
-566,964
| -95% | -$284M |
|
358
Tanger
SKT
$4.52B
| $15.3M | 0.01% |
459,942
-32,626
| -7% | -$1.09M |
|
|
PCH
359
DELISTED
PotlatchDeltic
PCH
| $15.3M | 0.01% |
385,337
+23,747
| +7% | +$961K |
|
360
LXP Industrial Trust
LXP
$3.57B
| $15.3M | 0.01% |
308,887
-20,173
| -6% | -$967K |
|
361
DexCom
DXCM
$32B
| $15.3M | 0.01% |
230,413
-33,151
| -13% | -$2.14M |
|
362
Micron Technology
MU
$991B
| $15.3M | 0.01% |
53,530
+4,408
| +9% | +$1.01M |
|
363
Insulet
PODD
$9.79B
| $15M | 0.01% |
52,735
+6,462
| +14% | +$2.02M |
|
364
Warner Bros
WBD
$67.1B
| $14.8M | 0.01% |
512,228
-34,931
| -6% | -$816K |
|
365
Credicorp
BAP
$30.7B
| $14.7M | 0.01% |
51,116
-2,252
| -4% | -$596K |
|
366
Trustmark
TRMK
$2.75B
| $14.5M | ﹤0.01% |
371,263
-29,578
| -7% | -$1.15M |
|
367
Domino's
DPZ
$11.6B
| $14.4M | ﹤0.01% |
34,632
+5,282
| +18% | +$2.2M |
|
368
United Therapeutics
UTHR
$23.1B
| $14.3M | ﹤0.01% |
29,357
+5,777
| +24% | +$2.69M |
|
369
ProPetro Holding
PUMP
$1.35B
| $14.2M | ﹤0.01% |
1,495,676
-118,965
| -7% | -$1.03M |
|
370
Ameris Bancorp
ABCB
$5.89B
| $14.2M | ﹤0.01% |
191,110
+14
| +0% | +$1.04K |
|
371
First Merchants
FRME
$2.67B
| $14.1M | ﹤0.01% |
375,276
-51,843
| -12% | -$1.92M |
|
372
SS&C Technologies
SSNC
$18.6B
| $13.9M | ﹤0.01% |
158,724
+45,094
| +40% | +$3.85M |
|
373
Steven Madden
SHOO
$3.55B
| $13.6M | ﹤0.01% |
326,014
+14
| +0% | +$540 |
|
374
Vanguard Long-Term Treasury ETF
VGLT
$10.1B
| $12.9M | ﹤0.01% |
231,049
-368,835
| -61% | -$21M |
|
375
Avient
AVNT
$4.19B
| $12.9M | ﹤0.01% |
412,649
-48,128
| -10% | -$1.49M |
|
Similar funds
Ken Fisher's Q4 2025 Portfolio in Review
As of Q4 2025, Ken Fisher held 1,126 positions worth $293B, up 6% from $276B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ken Fisher's Q4 2025 filing shows 112 new, 480 increased, 403 reduced and 109 closed positions. Its largest new stake was Belden: 369,776 shares worth $43.1M. The largest sale was iShares MBS ETF, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q4 2025 buy was Belden: 369,776 shares worth $43.1M.
- Ken Fisher added most to iShares 7-10 Year Treasury Bond ETF in Q4 2025, an estimated $4.56B increase.
- Ken Fisher's biggest Q4 2025 reduction was iShares MBS ETF, cutting an estimated $2.05B.
- Ken Fisher fully exited Infosys in Q4 2025, selling an estimated $146M.
- Ken Fisher's ten largest holdings make up 34% of its $293B portfolio in Q4 2025.
- Ken Fisher opened 112 new positions and closed 109 in Q4 2025.
- Ken Fisher's portfolio value rose 6% quarter-over-quarter to $293B.
Based on Fisher Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.